232 related articles for article (PubMed ID: 29858005)
1. Clinical features of sarcoidosis associated pulmonary hypertension: Results of a multi-national registry.
Baughman RP; Shlobin OA; Wells AU; Alhamad EH; Culver DA; Barney J; Cordova FC; Carmona EM; Scholand MB; Wijsenbeek M; Ganesh S; Birring SS; Kouranos V; O'Hare L; Baran JM; Cal JG; Lower EE; Engel PJ; Nathan SD
Respir Med; 2018 Jun; 139():72-78. PubMed ID: 29858005
[TBL] [Abstract][Full Text] [Related]
2. Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry.
Shlobin OA; Kouranos V; Barnett SD; Alhamad EH; Culver DA; Barney J; Cordova FC; Carmona EM; Scholand MB; Wijsenbeek M; Ganesh S; Lower EE; Engel PJ; Wort J; Price L; Wells AU; Nathan SD; Baughman RP
Eur Respir J; 2020 May; 55(5):. PubMed ID: 32139456
[TBL] [Abstract][Full Text] [Related]
3. Clinical Features and Outcomes of Patients with Sarcoidosis-associated Pulmonary Hypertension.
Parikh KS; Dahhan T; Nicholl L; Ruopp N; Pomann GM; Fortin T; Tapson VF; Rajagopal S
Sci Rep; 2019 Mar; 9(1):4061. PubMed ID: 30858405
[TBL] [Abstract][Full Text] [Related]
4. Interventional therapy in sarcoidosis-associated pulmonary arterial stenosis and pulmonary hypertension.
Liu L; Xu J; Zhang Y; Fang L; Chai Y; Niu M; Li S
Clin Respir J; 2017 Nov; 11(6):906-914. PubMed ID: 26666961
[TBL] [Abstract][Full Text] [Related]
5. The association between BNP, 6MWD test, DLCO% and pulmonary hypertension in sarcoidosis.
Mirsaeidi M; Omar HR; Baughman R; Machado R; Sweiss N
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):317-320. PubMed ID: 28079843
[TBL] [Abstract][Full Text] [Related]
6. Bosentan for sarcoidosis-associated pulmonary hypertension: a double-blind placebo controlled randomized trial.
Baughman RP; Culver DA; Cordova FC; Padilla M; Gibson KF; Lower EE; Engel PJ
Chest; 2014 Apr; 145(4):810-817. PubMed ID: 24177203
[TBL] [Abstract][Full Text] [Related]
7. An update on sarcoidosis-associated pulmonary hypertension.
Bandyopadhyay D; Humbert M
Curr Opin Pulm Med; 2020 Sep; 26(5):582-590. PubMed ID: 32740377
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary hypertension in chronic lung diseases.
Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
[TBL] [Abstract][Full Text] [Related]
9. Sarcoidosis-associated pulmonary hypertension in patients with near-normal lung function.
Maimon N; Salz L; Shershevsky Y; Matveychuk A; Guber A; Shitrit D
Int J Tuberc Lung Dis; 2013 Mar; 17(3):406-11. PubMed ID: 23407231
[TBL] [Abstract][Full Text] [Related]
10. Sarcoidosis-associated pulmonary hypertension.
Cordova FC; D'Alonzo G
Curr Opin Pulm Med; 2013 Sep; 19(5):531-7. PubMed ID: 23912192
[TBL] [Abstract][Full Text] [Related]
11. Survival in sarcoidosis-associated pulmonary hypertension: the importance of hemodynamic evaluation.
Baughman RP; Engel PJ; Taylor L; Lower EE
Chest; 2010 Nov; 138(5):1078-85. PubMed ID: 20348196
[TBL] [Abstract][Full Text] [Related]
12. Sarcoidosis-Associated Pulmonary Hypertension.
Huitema MP; Mathijssen H; Mager JJ; Snijder RJ; Grutters JC; Post MC
Semin Respir Crit Care Med; 2020 Oct; 41(5):659-672. PubMed ID: 32777851
[TBL] [Abstract][Full Text] [Related]
13. Prostacyclin and oral vasodilator therapy in sarcoidosis-associated pulmonary hypertension: a retrospective case series.
Bonham CA; Oldham JM; Gomberg-Maitland M; Vij R
Chest; 2015 Oct; 148(4):1055-1062. PubMed ID: 26437815
[TBL] [Abstract][Full Text] [Related]
14. The six-minute walk test in sarcoidosis associated pulmonary hypertension: Results from an international registry.
Gupta R; Baughman RP; Nathan SD; Wells AU; Kouranos V; Alhamad EH; Culver DA; Barney J; Carmona EM; Cordova FC; Huitema M; Scholand MB; Wijsenbeek M; Ganesh S; Birring SS; Price LC; Wort SJ; Shlobin OA
Respir Med; 2022 May; 196():106801. PubMed ID: 35316723
[TBL] [Abstract][Full Text] [Related]
15. Inhaled iloprost for sarcoidosis associated pulmonary hypertension.
Baughman RP; Judson MA; Lower EE; Highland K; Kwon S; Craft N; Engel PJ
Sarcoidosis Vasc Diffuse Lung Dis; 2009 Jul; 26(2):110-20. PubMed ID: 20560291
[TBL] [Abstract][Full Text] [Related]
16. Sarcoidosis-associated pulmonary hypertension: outcome with long-term epoprostenol treatment.
Fisher KA; Serlin DM; Wilson KC; Walter RE; Berman JS; Farber HW
Chest; 2006 Nov; 130(5):1481-8. PubMed ID: 17099027
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary hypertension in sarcoidosis.
Baughman RP; Engel PJ; Meyer CA; Barrett AB; Lower EE
Sarcoidosis Vasc Diffuse Lung Dis; 2006 Jun; 23(2):108-16. PubMed ID: 17937106
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary artery diameter to predict pulmonary hypertension in pulmonary sarcoidosis.
Huitema MP; Spee M; Vorselaars VM; Boerman S; Snijder RJ; van Es HW; Reesink HJ; Grutters JC; Post MC
Eur Respir J; 2016 Feb; 47(2):673-6. PubMed ID: 26493790
[No Abstract] [Full Text] [Related]
19. Riociguat for Sarcoidosis-Associated Pulmonary Hypertension: Results of a 1-Year Double-Blind, Placebo-Controlled Trial.
Baughman RP; Shlobin OA; Gupta R; Engel PJ; Stewart JI; Lower EE; Rahaghi FF; Zeigler J; Nathan SD
Chest; 2022 Feb; 161(2):448-457. PubMed ID: 34363816
[TBL] [Abstract][Full Text] [Related]
20. Six-minute walk test and health status assessment in sarcoidosis.
Baughman RP; Sparkman BK; Lower EE
Chest; 2007 Jul; 132(1):207-13. PubMed ID: 17625083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
